Form 4 for CYTK CYTOKINETICS INC
Accepted 2022-05-11 00:00:00 ET · period of report 2022-05-10 · accession 0001061983-22-000119 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-11 | 2022-05-10 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $0.00 | +5,000 | 12.3K | +68% | $0 |
| D | 2022-05-11 | 2022-05-10 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-10 | A | A | 5,000 | $0.00 | 12,302 | D | — | — | |
| 2 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-05-10 | A | A | 10,000 | $0.00 | 10,000 | D | $37.89 · — to 2032-05-10 | 10,000 Common Stock | (F2) Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023. |